AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder
Similar Posts
Hospital Patient Visits Unlikely to Return
to Pre-COVID-19 Levels in 2021TransUnion Healthcare explores what’s ahead for healthcare utilization As the COVID-19 pandemic continues to weigh on the healthcare…
EY Study: Lack of Autonomy and Patient Safety Driving Clinicians to Sound the Alarm for New Care Delivery Models
42% of clinician responses cite lack of autonomy or control as top reason to leave medicine Clinicians feel…
